The renal osteodystrophy pattern in Brazil and Uruguay: An overview

Kidney International, Supplement

Volumn 63, Issue 85, 2003, Pages

  Almeida Araújo, Sonia M Holanda ^a   Ambrosoni, Pablo ^a   Santos Lobão, Rosélia R ^a   Caorsi, Hena ^a   Moysés, Rosa M A ^a   Carvalho Barreto, Fellype ^a   Olaizola, Inés ^a   Cruz, Elisa A S ^a   Petraglia, Alicia ^a   Dos Reis, Luciene M ^a   Duarte, Maria Eugênia ^a   Jorgetti, Vanda ^a   Carvalho, Aluizio B ^a  

^a NONE

Author keywords

Aluminum; Bone biopsy; Dialysis; Secondary hyperparathyroidism

Indexed keywords

ADULT; AGE; ALUMINUM OVERLOAD; BONE BIOPSY; BRAZIL; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; FEMALE; GENDER; HEMODIALYSIS; HUMAN; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; MALE; NEGRO; PREVALENCE; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; RISK FACTOR; SYMPTOMATOLOGY; URUGUAY;

EID: 0038526468     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. CANNATA JB: Fernández-Martin JL: The clinical impact of aluminium overload in renal failure. Nephrol Dial Transplant 13(Suppl 2):9-12, 2002
2. DÍAZ LÓPEZ JB, JORGETTI V, CAORSI H, et al: Epidemiology of renal osteodystrophy in Iberoamerica. Nephrol Dial Transplant 13 (Suppl 3):41-45, 1998
3. CANNATA JB: Nephrology Forum. Hipokinetic azotemic osteodystrophy. Kidney Int 54:1000-1016, 1998
4. DOS REIS LM, TZANNO-MARTINS C, JORGETTI V: Histochemical staining of bone aluminum: Comparison of aluminon and acid solochrome azurine and their correlation with bone aluminum content. Rev Hosp Clin Fac Med Sao Paulo. Jul-Aug 52(4):171-174, 1997
5. STEHMAN-BREEN CO, SHERRARD D, WALKER A, et ah Racial differences in bone mineral density and among end-stage renal disease patients. Am J Kidney Dis 33(5):941-946, 1999
6. JORGETTI V, LÓPEZ BD, CAOERSE F, et al: Different patterns of renal osteodystrophy in Iberoamerica. Am J Med Sci 320(2):76-80, 2000
7. AFIFI A: Renal osteodystrophy in developing countries. Artif Organs 26(9):767-769, 2002
8. FERREIRA AF: Diagnosis of renal osteodystrophy: When and how to use biochemical markers and non-invasive methods; when bone biopsy is needed. Nephrol Dial Transplant 15(Suppl 5):8-14, 2000
9. SHERRARD DJ, HERCZ G, PEY Y, et al: The spectrum of bone disease in end-stage renal failure - An evolving disorder. Kidney Int 43:436-442, 1993
10. MONIER-FAUGÈRE M-C, MALLUCHE HH: Trends in renal osteodystrophy: A survey from 1983 to 1995 in a total of 2248 patients. Nephrol Dial Transplant 11(Suppl 3):111-120, 1996
11. CHERTOW GM, PLONE D, DILLON MA, et al: Hyperparathyroidism and dialysis vintage. Clin Nephrol 54(4):295-300, 2000
12. CUNDY T, HAND DJ, OLIVER DO, et al: Who gets renal bone disease before beginning dialysis? BMJ 290:271-275, 1985
13. NAVEH-MANY T, EPSTEIN E, SILVER J: Oestrogens and calcium regulatory hormones: Potential implications for bone. Curr Opin Nephrol Hypertens 4(4):319-323, 1995
14. GUPTA A, KALLENBACH LR, ZASUWA G, DIVINE GW: Race is a major determinant of secondary hyperparathyroidism in uremic patients. J Am Soc Nephrol 11:330-334, 2000
15. BELL NH, GREEN A, EPSTEIN S, et al: Evidence for alteration of the vitamin D-endocrine system in blacks. J Clin Invest 76:470-473, 1985
16. GHAZALI A, FARDELLONE P, PRUNA A, et al: Is low plasma 25-(OH) vitamin D major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol? Kidney Int 55:2169-2177, 1999
17. CANNATA JB, BRIGGS JD, JUNOR BJ, et al: Effect of acute aluminium overload on calcium and parathyroid-hormone metabolism. Lancet 1(8323):501-503, 1983
18. DIAS-CORTE C, FERNANDEZ-MARTIN JL, BARRETO S, et al: Effect of aluminium load on parathyroid hormone synthesis. Nephrol Dial Transplant 16(4):742-745, 2001
19. MALLUCHE HH, MONIER-FAUGÈRE M-C: Risk of adynamic disease in dialized patients. Kidney Int 42(Suppl 38):62-67, 1992